155 related articles for article (PubMed ID: 29970708)
1. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
Chen J; Sun MX; Hua YQ; Cai ZD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
4. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
Fu Y; Lan T; Cai H; Lu A; Yu W
Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data.
Ren HY; Sun LL; Li HY; Ye ZM
Biomed Res Int; 2015; 2015():160835. PubMed ID: 26618165
[TBL] [Abstract][Full Text] [Related]
8. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
9. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
11. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
13. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
16. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma.
Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T
J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
19. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]